<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Biontech Archives - Hubu.news</title>
	<atom:link href="https://hubu.news/tag/biontech/feed/" rel="self" type="application/rss+xml" />
	<link>https://hubu.news/tag/biontech/</link>
	<description>Germany &#38; Europe</description>
	<lastBuildDate>Sat, 09 May 2026 09:41:04 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://hubu.news/wp-content/uploads/2022/03/cropped-PNG3-32x32.png</url>
	<title>Biontech Archives - Hubu.news</title>
	<link>https://hubu.news/tag/biontech/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Curevac Founder Accuses Biontech Of Deception And Misleading Practices</title>
		<link>https://hubu.news/2026/curevac-founder-accuses-biontech-of-deception-and-misleading-practices/</link>
		
		<dc:creator><![CDATA[Chloe Price]]></dc:creator>
		<pubDate>Sat, 09 May 2026 09:41:04 +0000</pubDate>
				<category><![CDATA[Economy / Finance]]></category>
		<category><![CDATA[Accuses]]></category>
		<category><![CDATA[Biontech]]></category>
		<category><![CDATA[Curevac]]></category>
		<category><![CDATA[Deception]]></category>
		<category><![CDATA[Founder]]></category>
		<category><![CDATA[Misleading]]></category>
		<category><![CDATA[Practices]]></category>
		<guid isPermaLink="false">https://hubu.news/?p=79235</guid>

					<description><![CDATA[<p>Ingmar Hoerr, a founder of Curevac, has leveled severe accusations against Biontech. Speaking to &#8220;Der Spiegel&#8221;, Hoerr suggested&#8230;</p>
<p>The post <a href="https://hubu.news/2026/curevac-founder-accuses-biontech-of-deception-and-misleading-practices/">Curevac Founder Accuses Biontech Of Deception And Misleading Practices</a> appeared first on <a href="https://hubu.news">Hubu.news</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Biontech investors Strüngmann plan to back Sahin Türeci&#8217;s new biopharma startup.</title>
		<link>https://hubu.news/2026/biontech-investors-strungmann-plan-to-back-sahin-turecis-new-biopharma-startup/</link>
		
		<dc:creator><![CDATA[Sean Prescott]]></dc:creator>
		<pubDate>Fri, 13 Mar 2026 16:08:03 +0000</pubDate>
				<category><![CDATA[Economy / Finance]]></category>
		<category><![CDATA[Biontech]]></category>
		<category><![CDATA[Sahin]]></category>
		<category><![CDATA[Strüngmann]]></category>
		<category><![CDATA[Türecis]]></category>
		<guid isPermaLink="false">https://hubu.news/?p=72187</guid>

					<description><![CDATA[<p>The Strüngmann brothers, founders of BionTech, intend to invest in the new company that departing executives Ugur Sahin and&#8230;</p>
<p>The post <a href="https://hubu.news/2026/biontech-investors-strungmann-plan-to-back-sahin-turecis-new-biopharma-startup/">Biontech investors Strüngmann plan to back Sahin Türeci&#8217;s new biopharma startup.</a> appeared first on <a href="https://hubu.news">Hubu.news</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Biontech Founders Resign to Launch New mRNA Venture by End 2026</title>
		<link>https://hubu.news/2026/biontech-founders-resign-to-launch-new-mrna-venture-by-end-2026/</link>
		
		<dc:creator><![CDATA[Trevor Yard]]></dc:creator>
		<pubDate>Tue, 10 Mar 2026 20:29:04 +0000</pubDate>
				<category><![CDATA[Economy / Finance]]></category>
		<category><![CDATA[Biontech]]></category>
		<category><![CDATA[End]]></category>
		<category><![CDATA[Founders]]></category>
		<category><![CDATA[Launch]]></category>
		<category><![CDATA[Resign]]></category>
		<category><![CDATA[Venture]]></category>
		<guid isPermaLink="false">https://hubu.news/?p=71758</guid>

					<description><![CDATA[<p>Ugur Sahin and Özlem Türeci plan to step down from their leadership and board positions at BioNTech at the end&#8230;</p>
<p>The post <a href="https://hubu.news/2026/biontech-founders-resign-to-launch-new-mrna-venture-by-end-2026/">Biontech Founders Resign to Launch New mRNA Venture by End 2026</a> appeared first on <a href="https://hubu.news">Hubu.news</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Stuttgart Court Rejects BioNTech Appeal Over Vaccine Verdict</title>
		<link>https://hubu.news/2026/stuttgart-court-rejects-biontech-appeal-over-vaccine-verdict/</link>
		
		<dc:creator><![CDATA[Dawn Amber]]></dc:creator>
		<pubDate>Mon, 19 Jan 2026 14:56:05 +0000</pubDate>
				<category><![CDATA[Mixed]]></category>
		<category><![CDATA[Appeal]]></category>
		<category><![CDATA[Biontech]]></category>
		<category><![CDATA[Court]]></category>
		<category><![CDATA[REJECTS]]></category>
		<category><![CDATA[Stuttgart]]></category>
		<category><![CDATA[Vaccine]]></category>
		<category><![CDATA[Verdict]]></category>
		<guid isPermaLink="false">https://hubu.news/?p=65275</guid>

					<description><![CDATA[<p>The Federal Court of Justice (Bundesgerichtshof) is scheduled to address a related case against a different vaccine company&#8230;</p>
<p>The post <a href="https://hubu.news/2026/stuttgart-court-rejects-biontech-appeal-over-vaccine-verdict/">Stuttgart Court Rejects BioNTech Appeal Over Vaccine Verdict</a> appeared first on <a href="https://hubu.news">Hubu.news</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Biontech Clears Curevac Acquisition</title>
		<link>https://hubu.news/2025/biontech-clears-curevac-acquisition/</link>
		
		<dc:creator><![CDATA[Sean Prescott]]></dc:creator>
		<pubDate>Tue, 14 Oct 2025 13:15:05 +0000</pubDate>
				<category><![CDATA[Economy / Finance]]></category>
		<category><![CDATA[Acquisition]]></category>
		<category><![CDATA[Biontech]]></category>
		<category><![CDATA[Clears]]></category>
		<category><![CDATA[Curevac]]></category>
		<guid isPermaLink="false">https://hubu.news/?p=53385</guid>

					<description><![CDATA[<p>The German Federal Cartel Office (Bundeskartellamt) has approved the proposed acquisition of up to 100% of the shares&#8230;</p>
<p>The post <a href="https://hubu.news/2025/biontech-clears-curevac-acquisition/">Biontech Clears Curevac Acquisition</a> appeared first on <a href="https://hubu.news">Hubu.news</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>BioNTech Expands Cancer Research Trials</title>
		<link>https://hubu.news/2025/biontech-expands-cancer-research-trials/</link>
		
		<dc:creator><![CDATA[Dawn Amber]]></dc:creator>
		<pubDate>Mon, 28 Jul 2025 07:22:04 +0000</pubDate>
				<category><![CDATA[Economy / Finance]]></category>
		<category><![CDATA[Biontech]]></category>
		<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Expands]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[Trials]]></category>
		<guid isPermaLink="false">https://hubu.news/?p=43940</guid>

					<description><![CDATA[<p>Biotech firm BioNTech is accelerating its cancer research efforts in partnership with Bristol Myers Squibb (BMS), aiming to&#8230;</p>
<p>The post <a href="https://hubu.news/2025/biontech-expands-cancer-research-trials/">BioNTech Expands Cancer Research Trials</a> appeared first on <a href="https://hubu.news">Hubu.news</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Biontech to Take Over Curevac in $5.5 Billion Deal</title>
		<link>https://hubu.news/2025/biontech-to-take-over-curevac-in-5-5-billion-deal/</link>
		
		<dc:creator><![CDATA[Chloe Price]]></dc:creator>
		<pubDate>Thu, 12 Jun 2025 11:10:05 +0000</pubDate>
				<category><![CDATA[Economy / Finance]]></category>
		<category><![CDATA[Billion]]></category>
		<category><![CDATA[Biontech]]></category>
		<category><![CDATA[Curevac]]></category>
		<category><![CDATA[Deal]]></category>
		<category><![CDATA[Take]]></category>
		<guid isPermaLink="false">https://hubu.news/?p=37595</guid>

					<description><![CDATA[<p>Biontech Acquires Curevac in a Move to Strengthen mRNA-Based Cancer Immunotherapy Research and Development In a bid to&#8230;</p>
<p>The post <a href="https://hubu.news/2025/biontech-to-take-over-curevac-in-5-5-billion-deal/">Biontech to Take Over Curevac in $5.5 Billion Deal</a> appeared first on <a href="https://hubu.news">Hubu.news</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
